Lymphedema Prevention Through Immediate Lymphatic Reconstruction (LILY) Trial.

Part of paid clinical trials in Houston, Texas.

Sponsor
M.D. Anderson Cancer Center
Study ID
NCT06989099
Phase
PHASE2
Status
Recruiting
Apply to this trial

Conditions

  • Lymphedema

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Immediate Lymphatic Reconstruction (ILR)/ — PROCEDURE
    Given by Procedure
  • Prophylactic Lymphovenous Bypass (pLVB) — PROCEDURE
    Given by Procedure

Study Details

To learn if reconstruction of the lymphatic system at the time of axillary lymphadenectomy can reduce the risk of developing lymphedema.

Key Dates

Start date
Sep 24, 2024
Status verified
Feb 2026
Primary completion
Aug 1, 2028
Completion
Aug 1, 2029

Study Design

Enrollment
50 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION

Arms

  • Experimental: Postoperative Evaluations
    Participants who agree to take part in this study, clinic visit timing will be exactly the same time as would ordinarily be scheduled: before surgery, then 6, 12, 18, and 24 months after surgery. Each study visit should take about 2-3 hours.

Primary Outcome Measure

Freedom from lymphedema (FFL) [ Time Frame: 2 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
MD Anderson Cancer CenterHoustonTexas77030
Sara Hull, MHA, BA, BSN, RN, CCRP
[email protected]
713-794-1247
Mark Schaverien, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX

By research site
MD Anderson Cancer Center· Houston, TX

Related Studies